Absci Corp. (ABSI)
2.91
-0.25
(-7.91%)
USD |
NASDAQ |
Jan 23, 16:00
2.94
+0.03
(+1.03%)
After-Hours: 20:00
Absci Research and Development Expense (TTM): 74.45M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| CorMedix, Inc. | 12.46M |
| Verastem, Inc. | 103.74M |
| Fortress Biotech, Inc. | 22.21M |
| Anavex Life Sciences Corp. | 37.59M |
| Ocugen, Inc. | 35.49M |